The conduct of clinical research is essential to improving the treatment options of cancer patients. Many treatment protocols are complex and prescribed using electronic health record systems where the treatment protocol orders have been built previously. The work of building these treatment protocols is a complex process involving many steps, substantial time, and can be the limiting step in opening clinical trials. Multi-arm and protocol amendments can be particularly time consuming to build. Unfortunately for multi-site clinical trials, this build process is duplicated at each site representing a lack of efficiency in the overall clinical research system. This project seeks to bring together a consortium of NCI-designated cancer centers who are leaders in both the conduct of clinical research and in clinical informatics, along with coordination with EHR companies, to establish standardized build conventions, develop means to make clinical trial protocol builds interoperable across sites, and ultimately to make the conduct of clinical research substantially more efficient. In this way we will be able to better leverage the power of clinical informatics systems to accelerate the conduct of clinical cancer research.

Public Health Relevance

Currently every center opening a trial is required to build its own trial calendar in its electronic health record (EHR) system. The focus of this supplement is to standardize the calendar build across multiple NCI designated cancer centers to increase the collective efficiency of opening trials. This will dramatically improve the timeline for trial opening, resulting in NCI Cancer Centers being able to deliver treatment options more quickly to patients. Additionally it will reduce cost for clinical research, enabling more research opportunities and at more locations outside of major academic centers.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA046934-32S6
Application #
10225725
Study Section
Program Officer
He, Min
Project Start
1997-04-04
Project End
2022-01-31
Budget Start
2020-09-10
Budget End
2021-01-31
Support Year
32
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Maccini, Michael A; Westfall, Nicholas J; Van Bokhoven, Adrie et al. (2018) The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer. Prostate 78:506-511
Ye, Haobin; Adane, Biniam; Khan, Nabilah et al. (2018) Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells. Cancer Cell 34:659-673.e6
Flannery, Patrick C; DeSisto, John A; Amani, Vladimir et al. (2018) Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma. Oncol Rep 39:455-464
Elder, Alan M; Tamburini, Beth A J; Crump, Lyndsey S et al. (2018) Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer. Cancer Res 78:6473-6485
Yue, Zongliang; Zheng, Qi; Neylon, Michael T et al. (2018) PAGER 2.0: an update to the pathway, annotated-list and gene-signature electronic repository for Human Network Biology. Nucleic Acids Res 46:D668-D676
Smith, Weston J; Tran, Huy; Griffin, James I et al. (2018) Lipophilic indocarbocyanine conjugates for efficient incorporation of enzymes, antibodies and small molecules into biological membranes. Biomaterials 161:57-68
Morgan, Michael J; Fitzwalter, Brent E; Owens, Charles R et al. (2018) Metastatic cells are preferentially vulnerable to lysosomal inhibition. Proc Natl Acad Sci U S A 115:E8479-E8488
Hartwick, Erik W; Costantino, David A; MacFadden, Andrea et al. (2018) Ribosome-induced RNA conformational changes in a viral 3'-UTR sense and regulate translation levels. Nat Commun 9:5074
Genova, Carlo; Socinski, Mark A; Hozak, Rebecca R et al. (2018) EGFR Gene Copy Number by FISH May Predict Outcome of Necitumumab in Squamous Lung Carcinomas: Analysis from the SQUIRE Study. J Thorac Oncol 13:228-236
Greer, Robert O; Eskendri, Jeffrey; Freedman, Paul et al. (2018) Assessment of biologically aggressive, recurrent glandular odontogenic cysts for mastermind-like 2 (MAML2) rearrangements: histopathologic and fluorescent in situ hybridization (FISH) findings in 11 cases. J Oral Pathol Med 47:192-197

Showing the most recent 10 out of 1634 publications